
Genetron Holdings Limited GTH
Geschäftsbericht 2022
hinzugefügt 21.12.2024
Genetron Holdings Limited Betriebsaufwand 2011-2026 | GTH
Betriebsaufwand Jährlich Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 983 M | 856 M | 529 M | 452 M | 326 M | 181 M | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 983 M | 181 M | 554 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
9.98 M | $ 2.87 | -3.04 % | $ 93.1 K | ||
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.99 B | $ 118.59 | 0.39 % | $ 36.1 B | ||
|
Celcuity
CELC
|
113 M | $ 108.89 | 0.54 % | $ 4.3 B | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 27.69 | -1.07 % | $ 769 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 175.98 | -1.49 % | $ 8.72 B | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 13.9 | -2.11 % | $ 420 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
106 M | $ 16.01 | 1.62 % | $ 2.08 B | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.11 | -2.63 % | $ 1.41 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 209.65 | -0.29 % | $ 23.3 B | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 203.85 | -0.99 % | $ 145 B | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | $ 103.36 | 0.01 % | $ 19.5 B | ||
|
Bioventus
BVS
|
217 M | $ 8.85 | 0.91 % | $ 554 M | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.3 | -4.19 % | $ 292 M | ||
|
DexCom
DXCM
|
1.89 B | $ 73.26 | -0.7 % | $ 28.6 B | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 24.01 | -4.59 % | $ 254 M | ||
|
VolitionRx Limited
VNRX
|
28.3 M | $ 0.2 | -2.17 % | $ 19.2 M | ||
|
CareDx, Inc
CDNA
|
411 M | $ 18.74 | -0.03 % | $ 999 M | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 108.07 | -0.18 % | $ 8.91 B | ||
|
IDEXX Laboratories
IDXX
|
1.3 B | $ 639.3 | 0.41 % | $ 51.4 B | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
3.69 B | $ 130.84 | -1.54 % | $ 20.8 B | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Guardant Health
GH
|
226 M | $ 94.83 | 2.82 % | $ 11.9 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 283.93 | -0.81 % | $ 23.6 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 79.25 | 3.87 % | $ 5.35 B | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 174.04 | -0.14 % | $ 29.9 B | ||
|
Brainsway Ltd.
BWAY
|
29.2 M | $ 23.08 | -2.57 % | $ 99.4 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | - | - | $ 79.8 M | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 317.21 | -0.44 % | $ 27.1 B | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Myriad Genetics
MYGN
|
964 M | $ 5.32 | 6.19 % | $ 493 M | ||
|
NeoGenomics
NEO
|
430 M | $ 9.71 | 2.21 % | $ 1.24 B | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
258 M | $ 209.59 | 4.71 % | $ 20.6 B | ||
|
Pacific Biosciences of California
PACB
|
600 M | $ 1.55 | -4.63 % | $ 465 M | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 11.01 | -1.26 % | $ 2.39 B | ||
|
Precipio
PRPO
|
13.6 M | $ 24.7 | 0.08 % | $ 32.1 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B |